Skip to content

Centerline Biomedical vs Stereotaxis

Centerline Biomedical logo

Centerline Biomedical

A New Way to Envision Interventional Navigation

45 employees · est. 2014 · Cleveland, United States

VS
Stereotaxis logo

Stereotaxis

Pioneering Endovascular Robotics

200 employees · est. 1990 · United States

Stereotaxis is the older company (2014 vs 1990); Stereotaxis is the larger of the two.

Side-by-Side Comparison

Centerline Biomedical Stereotaxis
Founded
2014 1990 older
Headquarters
Cleveland, United States United States
Employees
45 200 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care, Medical Devices
Funding Stage
Series B Post-IPO Equity
Total Funding
$46.20M $105.00M
Funding Rounds
6 7
Services
Navigation technology to reduce radiation exposure, Real-time intra-operative positioning systems (IOPS®), 3D image guidance for endovascular procedures, Portable navigation systems for healthcare settings Not tracked yet
Target Customers
Interventional Radiologists, Vascular Surgeons, Healthcare Providers in Endovascular Therapy, Medical Institutions focusing on patient safety and innovation Not tracked yet
Taxonomy
Interventional NavigationSurgical NavigationPrecision HealthcareInterventional Vascular Procedures3D VisualizationMedical Imaging +8 Medical RoboticsEndovascular RoboticsRobotic CardiologyArrhythmia TreatmentCoronary Disease TreatmentInterventional Lab Technology +9
Website
centerlinebiomedical.com stereotaxis.com
Centerline Biomedical logo

About Centerline Biomedical

Centerline Biomedical, founded in 2014 in the United States, is an innovative player in the Biotechnology and Health Care industries. The company has carved a niche with its groundbreaking Intra-Operative Positioning System (IOPS™), a technology transforming surgical navigation by alleviating common...

Stereotaxis logo

About Stereotaxis

Stereotaxis is a biotechnology and health care startup based in the United States, founded in 1990. The company's slogan, "Pioneering Endovascular Robotics," encapsulates its focus on revolutionizing the treatment of arrhythmias and conducting endovascular procedures through cutting-edge robotic tec...

Also comparing in this category

Comparing more than these two?

Get Centerline Biomedical, Stereotaxis and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Centerline Biomedical compare?

A PDF of Centerline Biomedical and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Centerline Biomedical was founded in 2014, based in Cleveland, United States, with 45 employees. Centerline Biomedical, founded in 2014 in the United States, is an innovative player in the Biotechnology and Health Care industries. The company has carved a niche with its groundbreaking Intra-Opera. Stereotaxis was founded in 1990, based in United States, with 200 employees. Stereotaxis is a biotechnology and health care startup based in the United States, founded in 1990. The company's slogan, "Pioneering Endovascular Robotics," encapsulates its focus on revolutionizing.
Centerline Biomedical has raised $46.20M and Stereotaxis $105.00M. Latest stage: Centerline Biomedical Series B, Stereotaxis Post-IPO Equity.
Both work in Biotechnology and Health Care.

Compare Centerline Biomedical with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Centerline Biomedical on 12 Sep 2024, and Stereotaxis on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout